Mouse COVID-19 Monoclonal antibody
Order now: dominika@ksiazkiwnauce.pl
Mouse Anti-Human GRIM-19 monoclonal antibody |
|||
CABT-B230 | Creative Diagnostics | 100 μg | 795.6 EUR |
CA 19-9 mouse monoclonal antibody, clone X91 |
|||
4CA19-X91 | Origene Technologies GmbH | 1 mg | Ask for price |
Cd5 mouse monoclonal antibody, clone OX-19, FITC |
|||
SM258F | Origene Technologies GmbH | 100 µg | Ask for price |
Cd5 mouse monoclonal antibody, clone OX-19, FITC |
|||
SM258FS | Origene Technologies GmbH | 50 µg | Ask for price |
COVID-19 Envelope Protein Antibody |
|||
E38PA9967 | EnoGene | 100ul | 225 EUR |
Description: Available in various conjugation types. |
|||
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 4A5-19 |
|||
TA808700 | Origene Technologies GmbH | 100 µl | Ask for price |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 4A5-19 |
|||
TA808700S | Origene Technologies GmbH | 30 µl | Ask for price |
COVID-19 Spike glycoprotein Antibody |
|||
E38PA9966 | EnoGene | 100ul | 225 EUR |
Description: Available in various conjugation types. |
|||
Cd5 mouse monoclonal antibody, clone OX-19, Purified |
|||
SM258P | Origene Technologies GmbH | 250 µg | Ask for price |
Cd5 mouse monoclonal antibody, clone OX-19, Purified |
|||
SM258PS | Origene Technologies GmbH | 100 µg | Ask for price |
COVID-19 Nucleocapsid Protein Antibody |
|||
E38PA9965 | EnoGene | 100ul | 225 EUR |
Description: Available in various conjugation types. |
|||
CD173 mouse monoclonal antibody, clone 19-OLE, Purified |
|||
AM32305PU-N | Origene Technologies GmbH | 100 µg | Ask for price |
Hist1h2ail1 (pThr11) mouse monoclonal antibody, clone N123/19 |
|||
73-223 | Origene Technologies GmbH | 5 ml | Ask for price |
Hist1h2ail1 (pThr11) mouse monoclonal antibody, clone N123/19 |
|||
75-223 | Origene Technologies GmbH | 100 µl | Ask for price |
CA 19-9 mouse monoclonal antibody, clone 121SLE, Purified |
|||
AM33126PU-S | Origene Technologies GmbH | 100 µg | Ask for price |
CA 19-9 mouse monoclonal antibody, clone 121SLE, Purified |
|||
AM33126PU-T | Origene Technologies GmbH | 20 µg | Ask for price |
CA 19-9 mouse monoclonal antibody, clone SLA203, Purified |
|||
AM10037PU-N | Origene Technologies GmbH | 1 ml | Ask for price |
CA 19-9 mouse monoclonal antibody, clone SLA203, Purified |
|||
AM10037PU-S | Origene Technologies GmbH | 500 µl | Ask for price |
CNN1 mouse monoclonal antibody, clone CP-19, Aff - Purified |
|||
AM20594PU-N | Origene Technologies GmbH | 100 µg | Ask for price |
Mouse Anti-19-methyltestosterone monoclonal antibody, clone NT |
|||
CABT-L3097-100ug | Creative Diagnostics | 100 ug | 639.6 EUR |
Mouse Anti-19-methyltestosterone monoclonal antibody, clone NT |
|||
CABT-L3097-1mg | Creative Diagnostics | 1 mg | 1575.6 EUR |
Mucolipin 3 (MCOLN3) mouse monoclonal antibody, clone N268/19 |
|||
73-283 | Origene Technologies GmbH | 5 ml | Ask for price |
Mucolipin 3 (MCOLN3) mouse monoclonal antibody, clone N268/19 |
|||
75-283 | Origene Technologies GmbH | 100 µl | Ask for price |
Mouse Anti-Human CA 19-9 monoclonal antibody, clone JID310 |
|||
CABT-L2979-100uL500uL | Creative Diagnostics | 100 uL, 500 uL | 602.4 EUR |
Cytokeratin 19 (KRT19) mouse monoclonal antibody, clone 1H6, Ascites |
|||
AM06638SU-N | Origene Technologies GmbH | 100 µl | Ask for price |
Cytokeratin 19 (KRT19) mouse monoclonal antibody, clone 4E8, Ascites |
|||
AM06660SU-N | Origene Technologies GmbH | 100 µl | Ask for price |
Pan Cadherin mouse monoclonal antibody, clone CH-19, Supernatant |
|||
DM228 | Origene Technologies GmbH | 1 ml | Ask for price |
Pan Cadherin mouse monoclonal antibody, clone CH-19, Supernatant |
|||
DM228-05 | Origene Technologies GmbH | 500 µl | Ask for price |
Mouse Anti-Human Cytokeratin 19 monoclonal antibody, clone JID130 |
|||
CABT-L2992-100uL500uL | Creative Diagnostics | 100 uL, 500 uL | 602.4 EUR |
Mouse Monoclonal KLF4 Monoclonal Antibody |
|||
TA326714 | Origene Technologies GmbH | 100 µg | Ask for price |
Mouse Monoclonal KLF4 Monoclonal Antibody |
|||
TA326715 | Origene Technologies GmbH | 100 µg | Ask for price |
Cytokeratin 19 (KRT19) mouse monoclonal antibody, clone BS23, Ascites |
|||
AM33198SU-N | Origene Technologies GmbH | 1 ml | Ask for price |
Cytokeratin 19 (KRT19) mouse monoclonal antibody, clone BS23, Ascites |
|||
AM33198SU-S | Origene Technologies GmbH | 100 µl | Ask for price |
Mouse Monoclonal Lin28 Monoclonal Antibody |
|||
TA326716 | Origene Technologies GmbH | 100 µg | Ask for price |
Cytokeratin 19 (KRT19) mouse monoclonal antibody, clone BA17, Purified |
|||
SM1822P | Origene Technologies GmbH | 200 µg | Ask for price |
Cytokeratin 19 (KRT19) mouse monoclonal antibody, clone 9H8G6, Ascites |
|||
AM06287SU-N | Origene Technologies GmbH | 100 µl | Ask for price |
Cytokeratin 19 (KRT19) mouse monoclonal antibody, clone 4F12G9, Ascites |
|||
AM06300SU-N | Origene Technologies GmbH | 100 µl | Ask for price |
Cytokeratin 19 (KRT19) mouse monoclonal antibody, clone CK202, Purified |
|||
AM10026PU-N | Origene Technologies GmbH | 1 ml | Ask for price |
Cytokeratin 19 (KRT19) mouse monoclonal antibody, clone CK202, Purified |
|||
AM10026PU-S | Origene Technologies GmbH | 500 µl | Ask for price |
SARS-CoV-2 (COVID-19) NSP7 Antibody |
|||
9155-002mg | ProSci | 0.02 mg | 229.7 EUR |
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. NSP7 plays a role in viral RNA synthesis (3,4,5). It forms a hexadecamer with nsp8 (8 subunits of each) that may participate in viral replication by acting as a primase. Alternatively, it may synthesize substantially longer products than oligonucleotide primers. |
|||
SARS-CoV-2 (COVID-19) NSP7 Antibody |
|||
9155-01mg | ProSci | 0.1 mg | 594.26 EUR |
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. NSP7 plays a role in viral RNA synthesis (3,4,5). It forms a hexadecamer with nsp8 (8 subunits of each) that may participate in viral replication by acting as a primase. Alternatively, it may synthesize substantially longer products than oligonucleotide primers. |
|||
SARS-CoV-2 (COVID-19) NSP8 Antibody |
|||
9159-002mg | ProSci | 0.02 mg | 229.7 EUR |
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. NSP8 plays a role in viral RNA synthesis (3,4,5). Forms a hexadecamer with nsp7 (8 subunits of each) that may participate in viral replication by acting as a primase. Alternatively, it may synthesize substantially longer products than oligonucleotide primers (6). |
|||
SARS-CoV-2 (COVID-19) NSP8 Antibody |
|||
9159-01mg | ProSci | 0.1 mg | 594.26 EUR |
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. NSP8 plays a role in viral RNA synthesis (3,4,5). Forms a hexadecamer with nsp7 (8 subunits of each) that may participate in viral replication by acting as a primase. Alternatively, it may synthesize substantially longer products than oligonucleotide primers (6). |
|||
SARS-CoV-2 (COVID-19) NSP9 Antibody |
|||
9161-002mg | ProSci | 0.02 mg | 229.7 EUR |
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. NSP9 may participate in viral replication by acting as a ssRNA-binding protein (3). |
|||
SARS-CoV-2 (COVID-19) NSP9 Antibody |
|||
9161-01mg | ProSci | 0.1 mg | 594.26 EUR |
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. NSP9 may participate in viral replication by acting as a ssRNA-binding protein (3). |
|||
SARS-CoV-2 (COVID-19) NSP9 Antibody |
|||
9163-002mg | ProSci | 0.02 mg | 229.7 EUR |
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. NSP9 may participate in viral replication by acting as a ssRNA-binding protein (3). |
|||
SARS-CoV-2 (COVID-19) NSP9 Antibody |
|||
9163-01mg | ProSci | 0.1 mg | 594.26 EUR |
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. NSP9 may participate in viral replication by acting as a ssRNA-binding protein (3). |
|||
SARS-CoV-2 (COVID-19) NSP8 Antibody |
|||
9167-002mg | ProSci | 0.02 mg | 229.7 EUR |
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. NSP8 plays a role in viral RNA synthesis (3,4,5). Forms a hexadecamer with nsp7 (8 subunits of each) that may participate in viral replication by acting as a primase. Alternatively, it may synthesize substantially longer products than oligonucleotide primers (6). |
|||
SARS-CoV-2 (COVID-19) NSP8 Antibody |
|||
9167-01mg | ProSci | 0.1 mg | 594.26 EUR |
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. NSP8 plays a role in viral RNA synthesis (3,4,5). Forms a hexadecamer with nsp7 (8 subunits of each) that may participate in viral replication by acting as a primase. Alternatively, it may synthesize substantially longer products than oligonucleotide primers (6). |
|||
SARS-CoV-2 (COVID-19) NSP2 Antibody |
|||
9171-002mg | ProSci | 0.02 mg | 229.7 EUR |
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. NSP2 may play a role in the modulation of host cell survival signaling pathway by interacting with host PHB and PHB2. Indeed, these two proteins play a role in maintaining the functional integrity of the mitochondria and protecting cells from various stresses (3). |
|||
SARS-CoV-2 (COVID-19) NSP2 Antibody |
|||
9171-01mg | ProSci | 0.1 mg | 594.26 EUR |
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. NSP2 may play a role in the modulation of host cell survival signaling pathway by interacting with host PHB and PHB2. Indeed, these two proteins play a role in maintaining the functional integrity of the mitochondria and protecting cells from various stresses (3). |
|||
SARS-CoV-2 (COVID-19) NSP2 Antibody |
|||
9173-002mg | ProSci | 0.02 mg | 229.7 EUR |
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. NSP2 may play a role in the modulation of host cell survival signaling pathway by interacting with host PHB and PHB2. Indeed, these two proteins play a role in maintaining the functional integrity of the mitochondria and protecting cells from various stresses (3). |
|||
SARS-CoV-2 (COVID-19) NSP2 Antibody |
|||
9173-01mg | ProSci | 0.1 mg | 594.26 EUR |
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. NSP2 may play a role in the modulation of host cell survival signaling pathway by interacting with host PHB and PHB2. Indeed, these two proteins play a role in maintaining the functional integrity of the mitochondria and protecting cells from various stresses (3). |
|||
SARS-CoV-2 (COVID-19) NSP4 Antibody |
|||
9175-002mg | ProSci | 0.02 mg | 229.7 EUR |
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. NSP4 participates in the assembly of virally-induced cytoplasmic double-membrane vesicles necessary for viral replication (3)(4). |
|||
SARS-CoV-2 (COVID-19) NSP4 Antibody |
|||
9175-01mg | ProSci | 0.1 mg | 594.26 EUR |
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. NSP4 participates in the assembly of virally-induced cytoplasmic double-membrane vesicles necessary for viral replication (3)(4). |
|||
SARS-CoV-2 (COVID-19) NSP6 Antibody |
|||
9177-002mg | ProSci | 0.02 mg | 229.7 EUR |
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. NSP6 plays a role in the initial induction of autophagosomes from host reticulum endoplasmic. Later, it limits the expansion of these phagosomes that are no longer able to deliver viral components to lysosomes (3,4). |
|||
SARS-CoV-2 (COVID-19) NSP6 Antibody |
|||
9177-01mg | ProSci | 0.1 mg | 594.26 EUR |
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. NSP6 plays a role in the initial induction of autophagosomes from host reticulum endoplasmic. Later, it limits the expansion of these phagosomes that are no longer able to deliver viral components to lysosomes (3,4). |
|||
SARS-CoV-2 (COVID-19) ORF6 Antibody |
|||
9189-002mg | ProSci | 0.02 mg | 229.7 EUR |
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. ORF6 disrupts cell nuclear import complex formation by tethering karyopherin alpha 2 and karyopherin beta 1 to the membrane. Retention of import factors at the ER/Golgi membrane leads to a loss of transport into the nucleus. Thereby it prevents STAT1 nuclear translocation in response to interferon signaling, thus blocking the expression of interferon stimulated genes (ISGs) that display multiple antiviral activities(3). |
|||
SARS-CoV-2 (COVID-19) ORF6 Antibody |
|||
9189-01mg | ProSci | 0.1 mg | 594.26 EUR |
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. ORF6 disrupts cell nuclear import complex formation by tethering karyopherin alpha 2 and karyopherin beta 1 to the membrane. Retention of import factors at the ER/Golgi membrane leads to a loss of transport into the nucleus. Thereby it prevents STAT1 nuclear translocation in response to interferon signaling, thus blocking the expression of interferon stimulated genes (ISGs) that display multiple antiviral activities(3). |
|||
SARS-CoV-2 (COVID-19) ORF8 Antibody |
|||
9287-002mg | ProSci | 0.02 mg | 229.7 EUR |
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). SARS-CoV-2 virus proteins include structural proteins, non-structural proteins and accessory factors. The structure of SARS-CoV-2 consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. SARS-CoV-2 non-structural protein is ORF1ab that consists of 16 proteins (nsp1-nsp16), while accessory factors include ORF3a, ORF3b, ORF6, ORF7a, ORF7b, ORF8, ORF9b, ORF9c and ORF10. ORF8 may play a role in modulating host immune response (Probable). May play a role in blocking host IL17 cytokine by its interaction with host IL17RA (3). |
|||
SARS-CoV-2 (COVID-19) ORF8 Antibody |
|||
9287-01mg | ProSci | 0.1 mg | 594.26 EUR |
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). SARS-CoV-2 virus proteins include structural proteins, non-structural proteins and accessory factors. The structure of SARS-CoV-2 consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. SARS-CoV-2 non-structural protein is ORF1ab that consists of 16 proteins (nsp1-nsp16), while accessory factors include ORF3a, ORF3b, ORF6, ORF7a, ORF7b, ORF8, ORF9b, ORF9c and ORF10. ORF8 may play a role in modulating host immune response (Probable). May play a role in blocking host IL17 cytokine by its interaction with host IL17RA (3). |
|||
SARS-CoV-2 (COVID-19) ORF8 Antibody |
|||
9289-002mg | ProSci | 0.02 mg | 229.7 EUR |
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). SARS-CoV-2 virus proteins include structural proteins, non-structural proteins and accessory factors. The structure of SARS-CoV-2 consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. SARS-CoV-2 non-structural protein is ORF1ab that consists of 16 proteins (nsp1-nsp16), while accessory factors include ORF3a, ORF3b, ORF6, ORF7a, ORF7b, ORF8, ORF9b, ORF9c and ORF10. ORF8 may play a role in modulating host immune response (Probable). May play a role in blocking host IL17 cytokine by its interaction with host IL17RA (3). |
|||
SARS-CoV-2 (COVID-19) ORF8 Antibody |
|||
9289-01mg | ProSci | 0.1 mg | 594.26 EUR |
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). SARS-CoV-2 virus proteins include structural proteins, non-structural proteins and accessory factors. The structure of SARS-CoV-2 consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. SARS-CoV-2 non-structural protein is ORF1ab that consists of 16 proteins (nsp1-nsp16), while accessory factors include ORF3a, ORF3b, ORF6, ORF7a, ORF7b, ORF8, ORF9b, ORF9c and ORF10. ORF8 may play a role in modulating host immune response (Probable). May play a role in blocking host IL17 cytokine by its interaction with host IL17RA (3). |
|||
CD57 / HNK1 mouse monoclonal antibody, clone 6-13-19-1, Liquid |
|||
AM32415SU-N | Origene Technologies GmbH | 1 ml | Ask for price |
SARS-CoV-2 (COVID-19) Spike Antibody |
|||
3525-002mg | ProSci | 0.02 mg | 206.18 EUR |
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a Spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. Coronavirus invades cells through Spike (S) glycoproteins, a class I fusion protein. It is the major viral surface protein that coronavirus uses to bind to the human cell surface receptor. It also mediates the fusion of host and viral cell membrane, allowing the virus to enter human cells and begin infection (3). The spike protein is the major target for neutralizing antibodies and vaccine development (4). The protein modeling suggests that there is strong interaction between Spike protein receptor-binding domain and its host receptor angiotensin-converting enzyme 2 (ACE2), which regulate both the cross-species and human-to-human transmissions of COVID-19 (5). The recent study has shown that the SARS-CoV-2 spike protein binds ACE2 with higher affinity than SARS-CoV spike protein (6). |
|||
SARS-CoV-2 (COVID-19) Spike Antibody |
|||
3525-01mg | ProSci | 0.1 mg | 523.7 EUR |
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a Spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. Coronavirus invades cells through Spike (S) glycoproteins, a class I fusion protein. It is the major viral surface protein that coronavirus uses to bind to the human cell surface receptor. It also mediates the fusion of host and viral cell membrane, allowing the virus to enter human cells and begin infection (3). The spike protein is the major target for neutralizing antibodies and vaccine development (4). The protein modeling suggests that there is strong interaction between Spike protein receptor-binding domain and its host receptor angiotensin-converting enzyme 2 (ACE2), which regulate both the cross-species and human-to-human transmissions of COVID-19 (5). The recent study has shown that the SARS-CoV-2 spike protein binds ACE2 with higher affinity than SARS-CoV spike protein (6). |
|||
SARS-CoV-2 (COVID-19) NSP10 Antibody |
|||
9179-002mg | ProSci | 0.02 mg | 229.7 EUR |
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. NSP10 plays a pivotal role in viral transcription by stimulating both nsp14 3'-5' exoribonuclease and nsp16 2'-O-methyltransferase activities. Therefore it plays an essential role in viral mRNAs cap methylation (3). |
|||
SARS-CoV-2 (COVID-19) NSP10 Antibody |
|||
9179-01mg | ProSci | 0.1 mg | 594.26 EUR |
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. NSP10 plays a pivotal role in viral transcription by stimulating both nsp14 3'-5' exoribonuclease and nsp16 2'-O-methyltransferase activities. Therefore it plays an essential role in viral mRNAs cap methylation (3). |
|||
SARS-CoV-2 (COVID-19) ORF9b Antibody |
|||
9191-002mg | ProSci | 0.02 mg | 229.7 EUR |
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. ORF9b plays a role in the inhibition of host innate immune response by targeting the mitochondrial-associated adapter MAVS. Mechanistically, it usurps the E3 ligase ITCH to trigger the degradation of MAVS, TRAF3, and TRAF6. In addition, it causes mitochondrial elongation by triggering ubiquitination and proteasomal degradation of dynamin-like protein 1/DNM1L(3). |
|||
SARS-CoV-2 (COVID-19) ORF9b Antibody |
|||
9191-01mg | ProSci | 0.1 mg | 594.26 EUR |
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. ORF9b plays a role in the inhibition of host innate immune response by targeting the mitochondrial-associated adapter MAVS. Mechanistically, it usurps the E3 ligase ITCH to trigger the degradation of MAVS, TRAF3, and TRAF6. In addition, it causes mitochondrial elongation by triggering ubiquitination and proteasomal degradation of dynamin-like protein 1/DNM1L(3). |
|||
SARS-CoV-2 (COVID-19) NSP12 Antibody |
|||
9267-002mg | ProSci | 0.02 mg | 229.7 EUR |
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. NSP12 interacts with nsp7 and nsp8. |
|||
SARS-CoV-2 (COVID-19) NSP12 Antibody |
|||
9267-01mg | ProSci | 0.1 mg | 594.26 EUR |
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. NSP12 interacts with nsp7 and nsp8. |
|||
SARS-CoV-2 (COVID-19) NSP15 Antibody |
|||
9269-002mg | ProSci | 0.02 mg | 229.7 EUR |
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. NSP15 is a Mn2+-dependent, uridylate-specific enzyme, which leaves 2'-3'-cyclic phosphates 5' to the cleaved bond. |